After a 2-week treatment with beraprost ( 80 g twice a day orally ) , the cough threshold was significantly ( P < .05 ) decreased as compared with placebo [ 12.2 ( geometric standard error of the mean [ GSEM ] 1.5 ) M vs. 24.4 ( GSEM 1.3 ) ] .